A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) versus Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-Positive.
Phase of Trial: Phase III
Latest Information Update: 11 Jul 2018
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 04 Jun 2018 Status changed from active, no longer recruiting to completed.
- 16 May 2018 This trial has been completed in Belgium (end date: 2018-04-03)
- 11 May 2018 This trial has been completed in Germany, according to European Clinical Trials Database